在患有喘和没有喘的美国成年人中,对野火烟雾的认识
Maria C Mirabelli1, Tia C Dowling1,2, Lauren Freelander3
1Asthma and Air Quality Branch, Division of Environmental Health Science and Practice, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA, USA.
概括
患有喘的美国成年人对野火烟雾的认识较高,但总体而言,意识较低强调需要对烟雾风险进行公共卫生沟通.
科学领域:
- 环境健康 环境健康
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 野火烟雾对健康构成重大风险.
- 了解公众对野火烟雾的认识对于有针对性的健康传播至关重要.
研究的目的:
- 评估美国成年人对环境野火烟雾的认识.
- 为了比较患有喘和没有喘的成年人之间的意识.
主要方法:
- 对2021年ConsumerStyles调查数据的分析 (N=4085).
- 将自我报告的喘状况和烟雾意识与来自卫星的烟雾数据联系起来.
- 后勤回归模型用于估计流行率 (PRs) 和95%置信区间 (CI).
主要成果:
- 超过98%的美国成年人居住在至少有一天有中到高密度野火烟雾的地区.
- 森林火灾烟雾的整体意识为19%.
- 与没有喘的成年人相比,患有喘的成年人表现出更高的意识 (PR: 1.25) ,特别是在暴露于大量烟雾的地区.
结论:
- 尽管喘患者的意识更高,但整体的野火烟雾意识很低.
- 迫切需要加强关于野火烟雾及其相关健康风险的公共卫生传播.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
263
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
263
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
186
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
186


